(AGENPARL) - Roma, 2 Dicembre 2022 - (AGENPARL) – ven 02 dicembre 2022 Update from GOV.?UK for: News and communications ACMD advice on the classification and schedule of Remimazolam Page summary: Report from the Advisory Council on the Misuse of Drugs (ACMD) on the classification and schedule of Remimazolam. Change made: Firs…
[Go to the GOV.UK homepage](https://www.gov.uk)
GOV.UK
Update from GOV.?UK for:
News and communications
—————————————————————
[ACMD advice on the classification and schedule of Remimazolam](https://www.gov.uk/government/publications/acmd-advice-on-the-classification-and-schedule-of-remimazolam?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=a15c4f97-eb51-4f9f-a7c1-8b6ce17cd2bd&utm_content=immediately)
Page summary:
Report from the Advisory Council on the Misuse of Drugs (ACMD) on the classification and schedule of Remimazolam.
Change made:
First published.
Time updated:
11:00am, 2 December 2022
—————————————————————